178 related articles for article (PubMed ID: 12678726)
1. The 'other' telomerase inhibitors: non-G-quadruplex interactive agent, non-antisense, non-reverse transcriptase telomerase inhibitors.
Beltz LA
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):589-603. PubMed ID: 12678726
[TBL] [Abstract][Full Text] [Related]
2. Telomerase inhibitors as anticancer therapy.
Akiyama M; Hideshima T; Munshi NC; Anderson KC
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
[TBL] [Abstract][Full Text] [Related]
3. How to inhibit telomerase activity for cancer therapy.
Kyo S; Inoue M
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
[TBL] [Abstract][Full Text] [Related]
4. Telomerase inhibitors for the treatment of cancer: the current perspective.
Perry PJ; Arnold JR; Jenkins TC
Expert Opin Investig Drugs; 2001 Dec; 10(12):2141-56. PubMed ID: 11772310
[TBL] [Abstract][Full Text] [Related]
5. Telomeres and telomerase: Pharmacological targets for new anticancer strategies?
Pendino F; Tarkanyi I; Dudognon C; Hillion J; Lanotte M; Aradi J; Ségal-Bendirdjian E
Curr Cancer Drug Targets; 2006 Mar; 6(2):147-80. PubMed ID: 16529544
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
7. Targeting human telomerase by antisense oligonucleotides and ribozymes.
Folini M; Pennati M; Zaffaroni N
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727
[TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibitors: a patent review (2010-2015).
Man RJ; Chen LW; Zhu HL
Expert Opin Ther Pat; 2016 Jun; 26(6):679-88. PubMed ID: 27104627
[TBL] [Abstract][Full Text] [Related]
9. Editorial (Thematic Issue Role of Heteroaromatics as Anticancer Agents).
Kaur H
Anticancer Agents Med Chem; 2016; 16(10):1204. PubMed ID: 27592681
[No Abstract] [Full Text] [Related]
10. Agents that target telomerase and telomeres.
Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
[TBL] [Abstract][Full Text] [Related]
11. Targeting human telomerase in cancer therapy.
Huard S; Autexier C
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
[TBL] [Abstract][Full Text] [Related]
12. Design of telomerase inhibitors for the treatment of cancer.
Cairns D; Anderson RJ; Perry PJ; Jenkins TC
Curr Pharm Des; 2002; 8(27):2491-504. PubMed ID: 12369943
[TBL] [Abstract][Full Text] [Related]
13. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
14. Natural and pharmacological regulation of telomerase.
Mergny JL; Riou JF; Mailliet P; Teulade-Fichou MP; Gilson E
Nucleic Acids Res; 2002 Feb; 30(4):839-65. PubMed ID: 11842096
[TBL] [Abstract][Full Text] [Related]
15. Recent patents on anti-telomerase cancer therapy.
Agrawal A; Dang S; Gabrani R
Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):102-17. PubMed ID: 21854360
[TBL] [Abstract][Full Text] [Related]
16. Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors.
Saraswati AP; Relitti N; Brindisi M; Gemma S; Zisterer D; Butini S; Campiani G
Drug Discov Today; 2019 Jul; 24(7):1370-1388. PubMed ID: 31136800
[TBL] [Abstract][Full Text] [Related]
17. Telomerase and telomeres: from basic biology to cancer treatment.
Helder MN; Wisman GB; van der Zee GJ
Cancer Invest; 2002; 20(1):82-101. PubMed ID: 11855380
[TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibitors in cancer therapy: current status and future directions.
Incles CM; Schultes CM; Neidle S
Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
20. Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics.
Zvereva MI; Zatsepin TS; Azhibek DM; Shubernetskaya OS; Shpanchenko OV; Dontsova OA
Biochemistry (Mosc); 2015 Mar; 80(3):251-9. PubMed ID: 25761680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
